Print

Synageva BioPharma (GEVA) to Present at the Leerink Swann and Company Global Healthcare Conference 2013  
2/7/2013 6:19:01 AM

Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, today announced its presentation at the upcoming Leerink Swann Global Healthcare Conference 2013.
//-->